CV Protek started to implement a project to build the largest regional logistics center in Kazan.
The Rigla pharmacy chain has opened its 3000th pharmacy.
Sotex was ranked among the Top-10 Russian drug manufacturers by Forbes magazine.
Rafarma received a registration certificate for a new drug Imatango.
CV Protek launched a distance learning project University PRO within the framework of continuous pharmaceutical education.
CV Protek and Sechenov University signed an agreement to establish a joint venture for the development of telemedicine technologies.
TST Transservice received a certificate of the international standard ISO 9001: 2015 Quality management systems.
The Rigla pharmacy chain has opened its first innovative pharmacy in St. Petersburg.
Sotex received a GMP certificate from the Croatian Agency for Medical Products.
Rafarma started production of Rosustin and Pemelan anti-tumor drugs.
CV Protek has launched int operation new distribution center in Novosibirsk.
ZdravCity, an online drug ordering service, has become a partner of Mail.Ru Group.
The Rigla pharmacy chain and the ProApteka marketing association have launched an electronic purchasing system.
Protek Group has acquired the production facilities of Rafarma JSC, a full-cycle pharmaceutical production complex in the Terbuny industrial Complex in the Lipetsk Region.
As part of the investment program of the Protek Group, a new Transservice-2 warehouse complex has been put into operation, integrated with the infrastructure of CV Potek's distribution infrastructure.
The Rigla pharmacy chain has opened its 2000th pharmacy.
CV PROTEK has established marketing association ProApteka - a federal trade union of independent pharmacies.
Network of pharmacies Rigla overcame the threshold of 1.5 thousand pharmacies, celebrated its 15th anniversary in November.
Sotex was awarded with European Certificate of Compliance with International EU GMP Guidelines: Ampoule manufacturing site of SOTEX was awarded with the Certificate of National Institute of Pharmacy and Medication – pharmacovigilance authority in Portugal.
The company is celebrating its 25th anniversary. Over these years PROTEK has grown from a small company into the largest Russian pharmaceutical holding, passed different stages of its formation including building of a distribution business of the CV PROTEK, development of Rigla retail network, and Sotex expansion. An important step in the development of the company was entering the public capital markets through IPO (initial public offering) in 2010.
25 years is just the beginning, as PROTEK continues to make progress, constantly being improved and aiming at long and successful company history. PROTEK group of companies is proud of the results achieved and is confident in its future.
On November 11, 2015 the Ministry of Industry and Trade of the Russian Federation issued a Russian GMP certificate to CLOSED JOINT STOCK COMPANY FarFirm Sotex (Report No. GMP-0038-000082/15).
Sotex has introduced new pharmaceuticals to the national market such as Flamadex, Neipilept, Lipothioxon, Ketoaminol, Ornilatex, Selamerex. A new (third one) ampoule medication production train has been launched. This will allow Sotex to double its volume of injection drugs production.
FarmFirm Sotex won silver in the 2014 Ad Eaters and won Best Commercial Video 2014 in the contest for its promotional video of Influnet, AnviMax also became the winner of the First International Green Cross Pharmaceutical Award in the Pharmaceutical of the Year - Cold and Flu Medicine nomination.
CV PROTEK has started the construction of a new warehouse up to 42,000 pallet positions in Pushkino.
Opening of the 1000th Rigla pharmacy in Moscow, MEGA Teply Stan Shopping Center at the following address: Moscow Oblast, Leninsky District, Kaluzhskoye shosse, 21th km (or 41-st km MKAD).
PROTEK implemented an electronic system to exchange documents with customers, pharmacies and pharmacy chains. From this moment on, clients of the largest national distributor will be able to receive and sign all bills and invoices in electronic format.
CV PROTEK opened a new branch with storage facility of more than 1000 m2 in Yakutsk
CV PROTEK was acknowledged as "the most influential pharmaceutical distributor in 2012" and was ranked first in the appropriate rating category of influence of certain subjects on the pharmaceutical market in Russia in 2012. The rating was published by Pharmaceutical Vestnik newspaper.
CV PROTEK won the “IT-LEADER" prize in the "Chemical and pharmaceutical industry" nomination for its outstanding contribution to the development of information technologies in Russia.
SOTEX ”PHARM FIRM” CJSC and Human Stem Cell Institute OJSC (HSCI) signed the agreement for a new drug Neovaskulgen supply developed by HSCI and destined for lower limb ischemia treatment.
CV PROTEK Company was rated first in “Logistics Operator of Russia 2013” in “National operator of the supply chain in the pharmaceutical industry" category as well as it was acknowledged leader in the “Top-10 Leaders of the logistics services market”.
Rigla Company, the largest pharmacy chain on the Russian market, announced the launch of the franchising program.
CV PROTEK launched a new project - "Customer’s Portal" - a unique resource that provides additional opportunities for pharmacies. Pharmacy managers and pharmacists are given the opportunity to interact quickly with the distributors and receive the relevant industry information on one website.
In Russia’s largest companies ranking “Expert-400” PROTEK OJSC won the 65th place in terms of volume implementation for 2012 and the 71st place in the capitalization rating.
PROTEK Group placed the shares in the stock market.
PROTEK Group became the owner of the 51 % of the pharmacy chain Zhivika, and also got the 4 pharmacy chains: Panaceya in St. Petersburg and it’s region, Biofarm and New Pharmacy in Yaroslavl, TK TOKO in Novokuibyshevsk of the Samara region.
Pharmacy chain Rigla started up the new pharmacy brand - the discounter network Be Healthy.
The own brand of the Sotex company the medical drug Eralfon took the first place in the rating of the prescription medicines according to the results of the year2009.
Sotex enlarged the export market and started exporting of the medicals abroad.
Rigla pharmacy chain started the line of goods under their own trademark.
CV PROTEK modernized server based platforms on the basis of the IBM systems.
Rigla pharmacy chain started up “The Pharmacy of Future” in Moscow, equipped with a first in the world SPA-cabinet of the Vichy laboratory.
PROTEK Group and NP CVT HimRar concluded the contract for strategic partnership.
Sotex started issue of their new brand - medical product Likferr100.
Rigla pharmacy chain started working on the partnership program concerning the opening of pharmacies in the Magnolia grocery stores.
Rigla pharmacy chain became the partner of the largest Russian loyalty program “Communication Club”.
Rigla opened up the first shop of the goods for mothers and babies “Little, little and less”.
Rigla pharmacy chain has won a nomination “Pharmacy chain” of the most authoritative pharmaceutical award “Platinum Ounce”.
Sotex obtained a patent for establishing their own brand – oxidation preventive “Neiroks”.
PROTEK-Finance successfully passed a call-option of its bonds.
Distributor CV PROTEK won the Platinum Ounce award as the Company of the year.
Rigla pharmacy chain won the Platinum Ounce award in the Pharmacy chain category.
CV PROTEK brought in a new logistical system based on Interregional logistic centers.
Rigla pharmacy chain became a co-founder of the Pharmacy Guild Non-commercial Partnership for pharmacy branch promotion.
Rigla pharmacy chain and Ingosstrakh Insurance brought in the unique insurance product called Pharmacy.
Sotex company entered the top five of leading Russian manufacturers of pharmaceutical products.
President of the PROTEK Group Mr. Vadim Muzyaev won the Person of the year international award in category Contribution to the pharmaceutical industry development.
Chairman of the Board of Directors of ОАО PROTEK Mr. Vadim Yakunin established "Saint Bishop Gregory the Theologian" Fund.
CV PROTEK distributor leads the aggregate rating of pharmaceutical distributors.
CV PROTEK company launched interregional logistics centers in Samara, Kazan, Novosibirsk, Voronezh within new logistics structure.
Acquisition by CV PROTEK of AS-Buro distributor (Ekaterinburg).
CV PROTEK and Rigla pharmacy chain got the “Health Idea” prize for health promotion and improvement of quality of life.
CV PROTEK is recognized by the Chamber of Commerce and Industry of the Russian Federation as a reliable partner.
Rigla pharmacy chain started implementation of pharmaceutical insurance programs.
Rigla pharmacy chain opened the first children’s pharmacy.
Rigla pharmacy chain is recognized as Trademark No. 1 in Russia in the national contest.
Sotex launched a line of pre-filled syringes for production of innovative Russian-made bio-engineering medications. Production of Eralfon has been started.
Sotex joins Top Three leaders in the rating of Russian manufacturing companies by the aggregate indicator based on CMP Pharmexpert.
Getting of the IFRS auditors report by PwC for the 2006 IFRS financial statements of the Group.
Commissioning of the Transservice customs and warehouse terminal with the warehousing area of 56,000 sq.m., with a modern automated line of order collection for customers based in Moscow, Moscow Region and some regions of the Central district.
Integration of the O3 pharmacy chain into Rigla chain; rebranding of O3 pharmacies under the Rigla brand.
Commissioning of new procurement facilities in regions (St. Petersburg, Novosibirsk).
Launch of two own brands in Sotex.
Final settlement by Ingosstrakh Insurance Co. of the loss event of CV Protek. The total indemnity came circa USD 75 million, or some 1.97 billion roubles.
Bonded loan by PROTEK-Finance in the amount of RUB 5 billion was successfully placed. Most of the funds raised had been channeled for the development of the Retail Sales segment.
PROTEK commissions the first phase (27,000 palette holders) of the terminal for customs and warehouse processing of pharmaceuticals at the Transservice Customs Warehouse Terminal in the Pushkino district, Moscow region.
Rigla begins to re-brand its pharmacies.
CV PROTEK becomes one of the key partners of the government in implementing the Additional Medical Provision (DLO) program for benefit recipients.
A Sotex production plant to produce ampoule forms, with the capacity of up to 100 million ampoules a year, is commissioned in the Sergiyev-Posad district, Moscow region. The production facility was designed and built in accordance with the European GMP (Good Manufacturing Practice) production standards.
Rigla pharmacy chain ranks No. 2 among Russia’s pharmacy chains in terms of sales.
CV PROTEK’s cash flow exceeds USD 1.2 billion.
CV PROTEK’s total warehouse area exceeds 100,000 sq.m.
Spargo Technologies, the developer of information technology services for the pharmaceutical market participants, is incorporated.
Gazon, a new office and warehouse facility with an area of 18,000 sq.m, is launched in Moscow.
PROTEK-SVM, substance distributor and contractual producer of medications, is established.
Promofarm, a marketing company for the pharmaceutical producers and trademark holders, is incorporated.
OAO PROTEK (Parent Company) is established during reconstruction of the Group. OAO PROTEK consolidates the ownership of stakes of shares/stakes in share capitals of its subsidiaries and affiliates.
The CV PROTEK regional branch network is now comprised of 39 branches and 15 regional representative offices.
The range of products warehoused in Moscow now stands at 6,500 items. The total warehouse area owned by PROTEK comes to 62,000 sq.m.
The first Rigla pharmacy is launched.
CV PROTEK co-founds SoyuzFarma, the Association of Pharmaceutical Institutions.
CV PROTEK is awarded the medal of the Russian Academy of Medical Sciences, For the Achievements in and Contribution to the Development of New Forms of Cooperation between the Fundamental Science and Pharmaceutical Business.
The Company is awarded the Distributor of the Year title during the Platinum Ounce 2000 First Open Contest among the pharmaceutical industry professionals.
Sotex production company is established as part of strategic partnership with Lek, Alkaloid, and Nycomed companies and engages in packing and packaging of medications. Subsequently, the company will form the basis of PROTEK’s production segment.
According to independent ratings compiled by the Company magazine, CV PROTEK is among Top 20 most successful Russian companies.
CV PROTEK opens one of Eastern Europe’s largest office and warehouse facilities, with an area of 25,000 sq. m, in Moscow.
The 20th CV PROTEK branch office is incorporated
For the first time ever, CV Protek becomes the leader in ratings of Russia’s pharmaceutical products’ importers as of the year’s end. The Company’s price list now includes more than 1,000 medications. CV PROTEK is the first among Russian pharmaceutical distributors to start using modem communications with the pharmacies.
CV PROTEK starts working with the Russian producers of medications. First Company’s regional offices open for business in Volgograd and St. Petersburg.
CV PROTEK begins to import medications made by Hungarian Gedeon Richter. The list of suppliers expands to include contracts with other Hungarian pharmaceutical producers, such as AEGiS, Biogal, and Chinoin.
CV PROTEK reaches agreement to sign its first contract for supply of medications with Gedeon Richter, Hungary’s largest pharmaceutical company. CV PROTEK determines its priority business activity, which is the distribution of medical preparations.
CV PROTEK engages in various business activities, including information technologies.
November 21. CV PROTEK is incorporated.
